D'Alto, Michele <br/><br/>
Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.  [electronic resource] 

 -  Chest  02 2020 
 - 376-383 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1931-3543 
<br/><br/><label>Standard No.: </label>10.1016/j.chest.2019.09.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antihypertensive Agents--therapeutic use<br/>Atrial Remodeling<br/>Cardiac Catheterization<br/>Drug Therapy, Combination<br/>Echocardiography<br/>Epoprostenol--analogs & derivatives<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Natriuretic Peptide, Brain--blood<br/>Peptide Fragments--blood<br/>Phenylpropionates--therapeutic use<br/>Pulmonary Arterial Hypertension--blood<br/>Pyridazines--therapeutic use<br/>Retrospective Studies<br/>Risk Reduction Behavior<br/>Tadalafil--therapeutic use<br/>Treatment Outcome<br/>Vascular Resistance<br/>Vasodilator Agents--therapeutic use<br/>Ventricular Function, Right<br/>Ventricular Remodeling<br/>Walk Test